TTS 2024 Newsletter #1 - Calling all Transplantation Enthusiasts and Medical Innovators

As the Istanbul Congress approaches, we are committed to keeping the transplant community well-informed about the latest developments through a series of TTS 2024 Newsletters

This inaugural edition offers a comprehensive overview of the entire congress, and forthcoming issues will delve into specific sessions, themes, and noteworthy features. Stay tuned for in-depth insights into the upcoming event.

Just Released - Transplantation Direct - March Issue

The March issue of Transplantation Direct covers a broad cross-section in transplantation. Topics covered in kidney transplantation include microbiota diversity effects, B cell antigen presentation and rejection, significance of high EBV loads, use of extracorporal photopheresis, IgM DSA implications, urinary endotrophin as a biomarker, as well as CAR T cell therapy for PTLD and optimizing analgesia for live-donor nephrectomies. Topics in liver transplantation explored involve portopulmonary hypertension treatment in waiting-list patients, implications of sarcomatoid hepatocellular carcinoma, and CXCL8 as a biomarker of graft injury. In lung transplantation, there are articles on a surgical technique to avoid atrial fibrillation after transplantation, diagnosis and treatment of esophageal fistulas, transplantation for pulmonary AL amyloidosis, and a report on attitudes of recipients regarding pregnancy and parenthood. For those involved in heart transplantation, there is a study on risk factors related to severe acute kidney injury after allografting. On the topic of organ donation, an observational study explores still-existing disparities among Hispanic patients awaiting transplantation. We welcome you to visit our Transplantation Direct website for full and free open access to all of these articles.

Table of Contents

Kidney Transplantation

Liver Transplantation

Lung Transplantation

Heart Transplantation

Ethics

Erratum



TTS 2024 - Abstract Deadline is less then 2 weeks away!

Submitting an abstract to the TTS 2024 Congress offers a platform to showcase groundbreaking research, connect with global experts, and contribute to advancements in transplantation medicine, fostering collaboration and influencing the field's future direction.

Submission Deadline:
March 18, 2024

2024 Scientific Congress Awards

To be eligible, an individual must:
  • Submit an abstract to TTS 2024 as presenting author
  • Be a member in good standing of TTS
  • Be a trainee/fellow/PhD student OR Allied health professional OR resident of emerging economy nation
The TTS scientific congress awards are designed to help offset expenses incurred to attend the TTS congress in Istanbul (in-person ONLY) and are awarded based on the scientific merit of the applicants.

Award Application Deadline: April 26, 2024

2024 Mentee-Mentor Awards

The Transplantation Society, in collaboration with National and International Societies acknowledges the contribution of basic science to the field of transplantation by offering Mentee-Mentor awards.

International Basic and Translational Science Mentee-Mentor Awards

TTS-ISOT La Renon International Basic and clinical sciences Mentee-Mentor Awards

Award Application Deadline: April 26, 2024

Registration is open!

Hotel Reservations

Airline DIscosunt


TTS 2028 Congress - Call for Expressions of Interest

Deadline to submit your expression of interest is March 28, 2024
Based on regional rotation, The Transplantation Society (TTS) plans to hold its 2028 TTS Biennial Congress in East, South or Southeast Asia. The Congress is anticipated to be held over 4 to 5 days – Saturday/Sunday to a Wednesday.
TTS welcomes interested societies to submit an expression of interest (EOI) to host the 32nd International Congress of The Transplantation Society in 2028. TTS IHQ will then work with shortlisted Host Societies (HS) to collect the information required for Council’s consideration and approval.
The Congresses are major undertakings and will require extensive planning, preparation and collaboration between TTS and local hosts. Given the Society's Congresses attract 3,000 – 4,500 registrants recommended venues must accommodate up to 4,000 delegates.

2024 Education Committee Webinar Series

In collaboration with the various Committees and Sections of the Society, the Education Committee is proud to present a series of educational webinars that have been specially designed for the whole TTS membership. The series has been carefully curated with the aim of addressing a wide range of topics, and drawing on diverse expertise and perspectives from around the world. Covering ethical controversies, cutting edge science, and fundamental challenges in policy-making and clinical care for transplant recipients and donors, we hope the program will provide valuable and engaging opportunities for all members to advance their knowledge and skills.

Click an image below to visit the individual webinar page.

CME Accredited Online Ecucation Activity: Cytomegalovirus (CME)

Third-party educational activity (not developed by TTS) but open to the TTS community.
Join Drs. Kotton, Pereira, and Razonable as they discuss the management of cytomegalovirus (CMV) infection in solid organ transplant (SOT) patients. Topics covered include treatment challenges, laboratory testing, and new therapy for refractory or resistant CMV.

ISN-TTS Sister Transplant Centers Program

Developing Kidney Transplant Programs Worldwide: New Partnerships and Upgrades in the ISN-TTS Sister Transplant Centers Program

The ISN and The Transplantation Society (TTS) are pleased to announce that two newly formed partnerships have been accepted into the joint ISN-TTS Sister Transplant Centers (STC) Program:

  • Nigeria - USA: Federal Medical Centre Umuahia Abia State, Nigeria - University of Virginia Health Systems, USA
  • Colombia - USA Trio: Hospital Universitario San José de Popayán, Colombia - Fundación Valle del Lili, Colombia - Boston Children’s Hospital, USA

In addition, two partnerships have successfully upgraded to Level A, one to Level B, and the Fundacion Valle del Lili (Colombia)-Boston Children's Hospital (USA) partnership has graduated.

This graduate pair has achieved considerable success over the past eight years and is now supporting another emerging center in Colombia through an STC trio partnership formed earlier this year.

Find out more about these new and ongoing partnerships and explore the map of current ISN-TTS STC partnerships.

The program is a joint initiative between the ISN and TTS to help establish new kidney transplant centers and develop existing kidney transplant programs in emerging countries.

The two societies formally renewed their collaborative agreement earlier this year to continue advancing global kidney care through this program and other joint initiatives, including educational content and training support. Look out for more information on new joint initiatives in the coming weeks.

The ISN and TTS warmly congratulate the upgraded and graduated centers on all they have accomplished and wish the newly formed partnerships every success as they advance through the program.


Research Grants Program - Letter of Intent Deadline: April 30th, 2024

TTS will provide funding to three individual investigators to support their research in transplantation. The spectrum of studies includes basic, clinical/epidemiological and translational. This individual should have spent five years or less performing research in transplantation (and/or immunology relating to transplant) since obtaining their last doctoral degree (PhD, MD, PharmD, or equivalent). One of these research grants will be preferentially designated to TTS members from a low- or middle-income country. Please send application materials and any questions to jennifer.groverman@tts.org.
Please note, only applicants whose notice of intent is accepted by April 30th by our peer-review committee will be eligible to submit a full grant application.

Transplantation Journal Highlights

Transplantation - Social Media Content

The Promise of Complement Therapeutics in Solid Organ Transplantation
Transplantation is the ideal therapy for end-stage organ failure, but outcomes for all transplant organs are suboptimal, underscoring the need to develop novel approaches to improve graft survival and function. The complement system, traditionally considered a component of innate immunity, is now known to broadly control inflammation and crucially contribute to induction and function of adaptive T-cell and B-cell immune responses, including those induced by alloantigens.
Marginal Zone B Cells Are Necessary for the Formation of Antidonor IgG After Allogeneic Sensitization
The formation of anti–major histocompatibility complex (MHC) antibodies is a significant barrier for many patients awaiting organ transplantation. Patients with preformed anti-MHC antibodies have limited options for suitable donors, and the formation of donor-specific anti-MHC antibodies after transplantation is a harbinger of graft rejection. Despite the recognized importance of anti-MHC antibodies, the mechanisms responsible for the differentiation of B cells after exposure to allogeneic antigens are poorly understood.

Transplantation Direct - Social Media Content

Continuous Renal Replacement Therapy During Long-term Normothermic Machine Perfusion of Human Donor Livers for up to 7 D
Normothermic machine perfusion (NMP) is used to preserve and test donor livers before transplantation. During NMP, the liver is metabolically active and produces waste products, which are released into the perfusate. In this study, we describe our simplified and inexpensive setup that integrates continuous renal replacement therapy (CRRT) with NMP for up to 7 d. We also investigated if the ultrafiltrate could be used for monitoring perfusate concentrations of small molecules such as glucose and lactate.
The Use of Ex Situ Normothermic Machine Perfusion in Combined Cardiac and Liver Transplantation Procedures
Combined heart-liver transplantation (CHLT) is a complex procedure that treats multiorgan disease and organ failure. CHLT has become increasingly common in recent years because of advancements in surgical techniques and immunosuppression.The most common indications for CHLT include familial amyloidosis, cardiac cirrhosis caused by congenital heart disease and dilated cardiomyopathy, and homozygous familial hypercholesterolemia.Additionally, with the aging population, the need for cardiac interventions such as coronary artery bypass surgery in combination with liver transplantation is becoming increasingly common.There are several major challenges to the CHLT procedure, including hemodynamic instability following implantation and prolonged cold ischemia during organ preservation when managing the logistics of dual organ implantation or surgery.

Upcoming Webinar Presentations

Click an image below to visit the indiviual webinar page.

In Case You Missed It - Recent Recordings


In the News 

Guy Alexandre, Transplant Surgeon Who Redefined Death, Dies at 89

His willingness to remove kidneys from brain-dead patients increased organ viability while challenging the line between living and dead.
Guy Alexandre, a Belgian transplant surgeon who in the 1960s risked professional censure by removing kidneys from brain-dead patients whose hearts were still beating — a procedure that greatly improved organ viability while challenging the medical definition of death itself — died on Feb. 14 at his home in Brussels. He was 89.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada